These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 2430040

  • 1. Membrane-bound C4b interacts endogenously with complement receptor CR1 of human red cells.
    Kinoshita T, Medof ME, Hong K, Nussenzweig V.
    J Exp Med; 1986 Nov 01; 164(5):1377-88. PubMed ID: 2430040
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
    Medof ME, Kinoshita T, Nussenzweig V.
    J Exp Med; 1984 Nov 01; 160(5):1558-78. PubMed ID: 6238120
    [Abstract] [Full Text] [Related]

  • 3. Complement receptor is an inhibitor of the complement cascade.
    Iida K, Nussenzweig V.
    J Exp Med; 1981 May 01; 153(5):1138-50. PubMed ID: 6910481
    [Abstract] [Full Text] [Related]

  • 4. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME, Nussenzweig V.
    J Exp Med; 1984 Jun 01; 159(6):1669-85. PubMed ID: 6233387
    [Abstract] [Full Text] [Related]

  • 5. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK.
    J Immunol; 1986 Mar 15; 136(6):2216-21. PubMed ID: 2419425
    [Abstract] [Full Text] [Related]

  • 6. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T, Matsumoto M, Nakanishi I, Yasuda R, Seya T.
    J Biochem; 1992 May 15; 111(5):573-8. PubMed ID: 1386357
    [Abstract] [Full Text] [Related]

  • 7. Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
    Kinoshita T, Medof ME, Nussenzweig V.
    J Immunol; 1986 May 01; 136(9):3390-5. PubMed ID: 2420889
    [Abstract] [Full Text] [Related]

  • 8. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 01; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 9. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT.
    J Exp Med; 1988 Nov 01; 168(5):1699-717. PubMed ID: 2972794
    [Abstract] [Full Text] [Related]

  • 10. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T, Holers VM, Atkinson JP.
    J Immunol; 1985 Oct 01; 135(4):2661-7. PubMed ID: 3161944
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C, Bradt BM, Nemerow GR, Cooper NR.
    J Exp Med; 1988 Sep 01; 168(3):949-69. PubMed ID: 2844953
    [Abstract] [Full Text] [Related]

  • 12. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 13. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I, Fujita T, Nussenzweig V.
    Proc Natl Acad Sci U S A; 1979 Dec 01; 76(12):6596-600. PubMed ID: 293746
    [Abstract] [Full Text] [Related]

  • 14. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
    Fujita T, Tamura N.
    J Exp Med; 1983 Apr 01; 157(4):1239-51. PubMed ID: 6601177
    [Abstract] [Full Text] [Related]

  • 15. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y, Kinoshita T, Kozono H, Takeda J, Tanaka E, Hong K, Inoue K.
    J Exp Med; 1987 Jun 01; 165(6):1494-507. PubMed ID: 3495629
    [Abstract] [Full Text] [Related]

  • 16. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.